-
公开(公告)号:US20220241331A1
公开(公告)日:2022-08-04
申请号:US17612279
申请日:2020-05-19
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Yardena SAMUELS , Shelly KALAORA , Aviyah PERI , Nir FRIEDMAN , Shlomit REICH-ZELIGER , Erez GREENSTEIN
IPC: A61K35/17 , C07K14/47 , C07K14/725 , C07K14/82 , C12N5/0783
Abstract: A method of treating cancer in a subject is disclosed. The method comprises administering to the subject a therapeutically effective amount of T cells expressing a T cell receptor (TCR) having a CDR3 amino acid sequence selected from the group consisting of 199-210.
-
2.
公开(公告)号:US20240180966A1
公开(公告)日:2024-06-06
申请号:US18384390
申请日:2023-10-27
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Yardena SAMUELS , Nir FRIEDMAN , Aviyah PERI , Erez GREENSTEIN , Michal ALON
CPC classification number: A61K35/17 , A61K39/4611 , A61K2239/57
Abstract: A method of treating cancer in a subject is disclosed. The method comprises administering to the subject a therapeutically effective amount of a population of T cells, wherein an alpha chain of a TCR of at least 10% of the T cells of the population has a CDR3 amino acid sequence as set forth in SEQ ID NO: 6, and a beta chain of the CDR has a CDR3 amino acid sequence as set forth in SEQ ID NO: 7.
-
公开(公告)号:US20210315983A1
公开(公告)日:2021-10-14
申请号:US17092386
申请日:2019-05-14
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Yardena SAMUELS , Yochai WOLF , Osnat BARTOK
IPC: A61K39/00 , A61P35/00 , C12N5/09 , G01N33/574
Abstract: A method of identifying a neoantigen in a tumor of a subject is disclosed. The method comprises:
(a) culturing cells of the tumor under conditions which generate single cell clones of the tumor; and
(b) analyzing the single cell clones for expression of a neoantigen which is reactive with T cells from the subject, thereby identifying the neoantigen in a tumor of a subject.-
公开(公告)号:US20210154261A1
公开(公告)日:2021-05-27
申请号:US16633175
申请日:2018-07-24
Applicant: Yeda Research and Development Co. Ltd.
Inventor: Yardena SAMUELS , Rand ARAFEH , Karen FLORES , Rony SEGER , Ehud WAINSTEIN
IPC: A61K38/10 , A61K31/519 , A61K31/4184 , A61P35/00
Abstract: An article of manufacture is disclosed which comprises: (i) a peptide agent which is capable of preventing extracellular signal-regulated kinase1/2 (ERK) translocation into the nucleus; and (ii) a MEK inhibitor. Uses thereof are also disclosed.
-
-
-